| 1.70 Delayed Data As of Sep 20 |  -0.04 / -2.30%Today’s Change | 1.65 Today|||52-Week Range 7.57 | -39.72% Year-to-Date |
| Previous close | 1.74 |
| Today’s open | 1.72 |
| Day’s range | 1.65 - 1.74 |
| Volume | 1,064,850 |
| Average volume (3 months) | 921,506 |
| Market cap | $978.9M |
| Earnings growth (last year) | -675.14% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +2,067,803.02% |
| P/E ratio | -- |
| Price/Sales | 0.97 |
| Price/Book | 0.79 |
| No competitors data available. |
| Next reporting date | October 29, 2019 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $39.8M |
| Annual profit (last year) | -$66.6M |
| Net profit margin | -167.53% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Adam Bierman |
President & Director Andrew Modlin |
Corporate headquarters Culver City, California |
